Vanguard Group’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,754,343
Closed -$187M 4183
2019
Q3
$187M Sell
2,754,343
-73,922
-3% -$5.01M 0.01% 1371
2019
Q2
$165M Buy
2,828,265
+305,047
+12% +$17.7M 0.01% 1473
2019
Q1
$177M Buy
2,523,218
+186,765
+8% +$13.1M 0.01% 1420
2018
Q4
$150M Buy
2,336,453
+184,521
+9% +$11.9M 0.01% 1429
2018
Q3
$151M Buy
2,151,932
+337,664
+19% +$23.7M 0.01% 1574
2018
Q2
$91.4M Buy
1,814,268
+135,314
+8% +$6.82M ﹤0.01% 1826
2018
Q1
$52.5M Buy
1,678,954
+34
+0% +$1.06K ﹤0.01% 2048
2017
Q4
$57.4M Sell
1,678,920
-202
-0% -$6.91K ﹤0.01% 1997
2017
Q3
$53.9M Buy
1,679,122
+8,500
+0.5% +$273K ﹤0.01% 2006
2017
Q2
$54.4M Buy
1,670,622
+106,452
+7% +$3.47M ﹤0.01% 1978
2017
Q1
$49.3M Buy
1,564,170
+126,807
+9% +$3.99M ﹤0.01% 2014
2016
Q4
$42.2M Buy
1,437,363
+45,579
+3% +$1.34M ﹤0.01% 2062
2016
Q3
$40.3M Buy
1,391,784
+22,977
+2% +$664K ﹤0.01% 2032
2016
Q2
$35.4M Buy
1,368,807
+42,512
+3% +$1.1M ﹤0.01% 2052
2016
Q1
$32.9M Buy
1,326,295
+36,445
+3% +$903K ﹤0.01% 2070
2015
Q4
$45.4M Buy
1,289,850
+42,803
+3% +$1.51M ﹤0.01% 1918
2015
Q3
$26.4M Buy
1,247,047
+67,899
+6% +$1.44M ﹤0.01% 2163
2015
Q2
$32.8M Buy
1,179,148
+99,305
+9% +$2.76M ﹤0.01% 2138
2015
Q1
$33M Buy
1,079,843
+101,664
+10% +$3.11M ﹤0.01% 2116
2014
Q4
$31.3M Buy
978,179
+4,319
+0.4% +$138K ﹤0.01% 2054
2014
Q3
$27.6M Buy
973,860
+21,103
+2% +$597K ﹤0.01% 2085
2014
Q2
$26.1M Sell
952,757
-242
-0% -$6.63K ﹤0.01% 2114
2014
Q1
$25.1M Buy
952,999
+55,156
+6% +$1.45M ﹤0.01% 2110
2013
Q4
$26.3M Buy
897,843
+30,730
+4% +$899K ﹤0.01% 2067
2013
Q3
$26.5M Buy
867,113
+38,803
+5% +$1.19M ﹤0.01% 2015
2013
Q2
$26.3M Buy
+828,310
New +$26.3M ﹤0.01% 1967